Clinical Software in Pennsylvania

Drummond Scientific Company is a contract development and manufacturing organization (CDMO) specializing in life science and in vitro diagnostic (IVD) products. Established over 75 years ago, the company designs, develops, and manufactures scientific instruments and custom automated solutions for clinical laboratories, IVF facilities, diagnostics, and point-of-care testing applications. Core product lines include the Nanoject series (micropipette pulling systems), Pipet-Aid pipette controllers, and specialized capillary sample tubes in glass and plastic. Drummond operates an integrated vertical manufacturing environment with in-house engineering, fabrication, quality assurance, and equipment servicing capabilities. The company offers contract manufacturing services, automated lateral flow assembly solutions for rapid test cassette production, and custom capillary development. ISO 13485:2016 certified (FM745098), Drummond serves research institutions, diagnostic manufacturers, and medical device companies requiring scalable prototype-to-production capabilities. Off-the-shelf products and replacement components are available through shop.drummondsci.com.

ATMOS Medizintechnik is a German-headquartered medical technology manufacturer with over 130 years of expertise and 300+ employees worldwide. The company develops and supplies medical suction systems, ENT (otolaryngology) workstations and treatment units, gynecology diagnostic and therapeutic equipment, and flexible endoscopy systems for swallowing diagnostics (FEES). ATMOS maintains 15 subsidiaries and approximately 70 national agencies internationally, serving hospitals, clinics, private practices, and homecare providers. Core product lines include electrical and pneumatic suction devices (ATMOS and MEDAP brands), ENT treatment units (C 21/C 31 Economy series, S 61 CORIAN), flexible HD video endoscopes (ATMOS Scope), ENT case management software, and gynecology solutions focused on cervical cancer diagnosis and treatment. The company emphasizes intuitive design, high infection control standards, workflow optimization, and user safety. ATMOS offers comprehensive post-sale services including technical support, repairs, maintenance, spare parts supply, and device modernization. Products are designed for clinical environments with emphasis on ease of use and reliability for end-users. The company maintains ISO and CE certifications typical of European medical device manufacturers and distributes globally through both direct channels and regional representatives.

Pronia Medical Systems develops GlucoCare, an FDA-cleared insulin dosing calculator software designed for critical care settings. GlucoCare is a web-based medical device that runs on standard browsers within hospital intranets or via cloud deployment, requiring minimal IT infrastructure for installation. The system implements the Yale Protocol—a customized, patient-response-based insulin dosing algorithm that accounts for current blood glucose, prior glucose trends, measurement intervals, and current insulin rate to calculate real-time insulin resistance and recommend safe dose adjustments. Clinical evidence demonstrates GlucoCare achieves hypoglycemia rates below 0.2% for readings <70 mg/dL while maintaining target glucose ranges. The platform supports multiple protocol variants (GlucoCare-140, GlucoCare-160) with configurable target ranges (100–160 mg/dL) and allows clinician overrides with quality assurance documentation. Built-in analytics provide unit-level and individual-user tracking for glucose control compliance and protocol adherence, enabling continuous quality improvement. GlucoCare integrates with hospital EMR systems and has been validated in peer-reviewed literature (Diabetes, Technology and Therapeutics). The company partners with EHR platforms including Cerner-based systems. Intended users are primarily nurses and critical care teams in hospital ICU settings managing patients requiring insulin infusions.

NextGen LifeLabs, established in 2012, is a family-owned and operated distributor and customizer of specialized equipment and services for Assisted Reproductive Technology (ART) laboratories. The company provides cutting-edge laboratory equipment, comprehensive installation, validation, and preventative maintenance services. Product offerings include ASTEC benchtop incubators (EC10 Dual Channel Digital Thermometer, Metrum 2), VITROLIFE modular laser systems for IVF applications, air quality management systems (LIFEAIRE advanced in-line filters), and customizable IVF workstations designed to meet individual laboratory workflows. Services encompass lab design consultation, equipment customization, delivery and installation, electronic witnessing system support, and andrology/consumables provision. The company leverages over 50 years of combined technical expertise and maintains partnerships with leading manufacturers including Eppendorf, Sensaphone, and OvationFertility. NextGen operates from its headquarters in Warminster, Pennsylvania, offering white-glove service and preventative maintenance programs to ensure equipment validation and optimal performance.

Tobii Dynavox is a global provider of augmentative and alternative communication (AAC) solutions for people with communication disabilities caused by conditions including ALS, autism, cerebral palsy, Rett syndrome, and other neurological conditions. The company designs purpose-built, customizable assistive communication devices and software platforms that enable clinicians to establish therapeutic goals and adapt solutions to meet clients' evolving needs. Core product lines include the TD I-Series, an eye-tracking-enabled Windows-based speech-generating device (SGD) with outdoor eye-tracking capability, and the TD Navio, an iOS-based touch-screen SGD with pre-loaded AAC applications. Both devices support multiple input modalities and are designed for individuals with severe speech and motor impairments. Tobii Dynavox emphasizes clinical training, professional education, and user success stories across diverse age groups and diagnoses. The company serves clinicians, healthcare facilities, educational institutions, and individual consumers seeking evidence-based AAC technology. While specific regulatory certifications are not detailed in the available content, AAC devices of this type typically require FDA clearance and conformance to accessibility standards. Tobii Dynavox maintains a global presence with regional sites serving North America, Europe, and Asia-Pacific markets.

Impilo Health is a remote patient monitoring and homecare logistics platform providing end-to-end support for virtual care programs. The company specializes in identifying and enrolling patients into remote monitoring programs, fulfilling and shipping customizable, white-label medical device kits directly to patient homes, and managing device data and patient engagement through a unified dashboard and API. Impilo handles the operational and logistical burden of remote care delivery, including patient education, device activation support, and data analytics for population health management. The platform integrates with existing EHR and digital health systems via API and SDK, enabling seamless data synchronization and unified visualization of patient wellness data. Impilo serves health systems, digital health companies, and virtual care providers nationwide. The company is FDA registered, DME accredited, and pursuing ISO 13485 certification. Compliance includes HIPAA and SOC 2. Core capabilities include white-glove logistics management, patient enrollment and support services, dashboard analytics, and interoperability with popular health devices and workflows.

Smartbox Assistive Technology develops augmentative and alternative communication (AAC) software and hardware solutions for individuals with speech and communication disabilities. The company's primary product, Grid, is a comprehensive AAC platform available across multiple devices including iPad and specialized hardware. Grid enables users with conditions such as cerebral palsy, autism, stroke, motor neuron disease, and other speech disabilities to communicate, access applications, operate computers, and control their environment. The platform incorporates AI-powered features like Smart Prompt, which allows users to create customized communication tools through natural language instructions. Smartbox serves children and adults globally through direct-to-consumer channels and professional partnerships with speech-language pathologists (SLPs), educators, and healthcare providers. The company provides clinical training through its SLP Education Program and maintains a team of Clinical AAC Specialists. Product offerings include Grid for iPad (available at promotional pricing), hardware-integrated AAC devices, and Symoji, a symbol-based communication system designed for classroom and educational settings. The company supports multiple access methods including dual-access capabilities for users with varied motor control needs. Smartbox operates internationally with regional support across the UK, US, Australia, and Europe, offering localized content and professional resources for implementers.

RemetricHealth is a remote patient monitoring (RPM) and chronic care management provider serving physician groups, hospitals, home health agencies, community health centers, and payers across the United States. The company delivers real-time biometric and compliance monitoring combined with clinical nursing services to assess patients remotely between office visits. Core offerings include FDA-cleared wireless biometric devices (primarily blood pressure monitors, glucose meters, and weight scales), a HIPAA-compliant web portal and mobile applications for both healthcare staff and patients, and clinical support services performed by RemetricHealth's nursing staff. The platform provides real-time data visualization, trend reporting, and automated alerts for out-of-range readings. RemetricHealth specializes in monitoring chronic conditions including congestive heart failure (CHF), hypertension, chronic obstructive pulmonary disease (COPD), and diabetes. The company is FDA-registered and ISO 13485–certified, ensuring regulatory compliance for its devices, portals, and applications. RemetricHealth operates a nursing team that performs patient assessments, provides wellness checks, medication adjustment coordination, patient education, and responsive follow-up via phone, text, and email. The solution is designed to reduce unnecessary hospital admissions and emergency department visits while improving patient engagement and clinical outcomes. The platform integrates with existing healthcare workflows and supports CPT-based reimbursement models for RPM and chronic care management services.

Fujirebio Holdings, Inc. is a subsidiary of H.U. Group Holdings Inc. that specializes in in vitro diagnostics (IVD) biomarker innovation and Contract Development & Manufacturing Organization (CDMO) services. The company drives the biomarker-to-IVD journey through research, clinical validation, and manufacturing partnerships, with a focus on transformative diagnostic solutions across multiple disease areas. Fujirebio's core offering includes the Lumipulse® platform, a fully automated immunoassay system for clinical laboratory testing, alongside manual and semi-automated assay kits (INNO-LIA®, INNO-LiPA®, INNOTEST®, CanAg®). The company manufactures diagnostic instruments, assay kits, software (LIRAS®), quality controls, and raw materials (antibodies and antigens). Primary clinical specialties include neurodegeneration (Alzheimer's disease, multiple sclerosis, Parkinson's disease, ALS), with blood-based biomarkers for amyloid and phosphorylated tau; infectious diseases (HPV genotyping, HPV screening); autoimmune disorders; cardiac markers; tumor markers; fertility and endocrinology; diabetes; and bone metabolism. Recent FDA clearances include blood-based Alzheimer's disease diagnostic tests. The company maintains regulatory credentials including FDA 510(k) clearances and CE marking. Fujirebio operates globally with CDMO partnerships, providing diagnostic raw materials, reagents, and full development and manufacturing services to technology partners and clinical laboratories.

WoundMatrix is a cloud-based mobile wound documentation and telehealth platform designed for secure capture, measurement, and upload of wound images and clinical data at the point of care. The solution comprises a mobile application (tablet-based) paired with a Health-Enabled Cloud environment for centralized image reading, data analytics, and outcome tracking. Core capabilities include objective wound measurement technology (validated against Johns Hopkins clinical studies to reduce measurement variability), real-time data collection and analytics, customizable data fields for organizational standardization, and powerful outcome tracking reports for identifying trends and improving patient care quality. The platform is HIPAA-compliant and 21 CFR Part 11 validated, supporting both standalone cloud deployment and EHR integration. WoundMatrix serves private sector, governmental, and educational healthcare organizations, particularly those managing community wound care programs. The company partners with major health IT providers (Insight Enterprises) and integrates with leading UK electronic patient record systems (Rio EPR). WoundMatrix holds UKCA marking for UK market deployment and is accredited with the Association of British HealthTech Industries (ABHI) and the Professional Record Standards Body (PRSB), positioning it for adoption across NHS community services. The platform emphasizes ease of use, scalability to any organization size, and clinician-centric mobile workflows for wound documentation and remote care coordination.

DEXIS is a global dental imaging and software company with 70 years of operational history and approximately 1,300 employees. The organization manufactures and distributes an integrated digital ecosystem for dental practices, combining 2D and 3D imaging, intraoral scanning, diagnostics, and treatment planning software. Their product portfolio includes extraoral CBCT systems (i-CAT and ORTHOPANTOMOGRAPH OP 3D series), intraoral X-ray units (including the NOMAD Pro 2 handheld portable system, which features 7x less radiation leakage at the trigger than leading competitors), intraoral scanners (DEXIS Imprevo and IS 3800 series with IS ScanFlow software), and DTX Studio Clinic—an AI-powered diagnostic and treatment planning platform. The Imprevo scanner recently received industry recognition. DEXIS solutions serve dental practices globally, with 165,000 solutions reported in use worldwide. The platform integrates image acquisition, patient data consolidation, AI-assisted diagnostics, surgical guide generation, and patient education into a single workflow. Products are built for private practices, dental groups, and specialists. The company offers a 60-day satisfaction guarantee. Regulatory credentials visible include CE marking and MD (Medical Device) designations for various products; specific FDA 510(k) status not explicitly stated on homepage but implied by device classification.

Omnicell, Inc. is a leading provider of pharmacy automation, medication management, and supply chain visibility solutions for healthcare organizations. The company specializes in automated dispensing systems, robotic medication management, and intelligent software platforms designed to reduce medication errors, improve operational efficiency, and optimize pharmacy supply chains. Omnicell's product portfolio includes the Titan XT, a next-generation automated dispensing system, along with smart devices for medication inventory management, and OmniSphere, a cloud-based software platform offering pharmacy supply chain analytics and visibility. The company serves hospitals, health systems, and pharmacy operations across the United States and internationally. Omnicell's solutions focus on autonomous pharmacy workflows, IV compounding automation, perioperative medication management, and clinic-based dispensing. The company demonstrates commitment to cybersecurity and regulatory compliance, with OmniSphere holding HITRUST CSF (Common Security Framework) i1 certification. Omnicell maintains service and support operations including expert technicians and strategic consulting to maximize technology adoption and clinical outcomes. The company operates innovation labs and continues product development for emerging healthcare settings including perioperative and ambulatory clinic environments.

Circadiance is a medical device company founded in 2006 specializing in remote patient monitoring solutions and respiratory care products. The company develops and manufactures cloud-based monitoring hardware and software designed for hospitals and home care providers, with particular focus on neonatal and pediatric populations. Circadiance is renowned for its SleepWeaver® soft cloth CPAP masks, which offer enhanced comfort for obstructive sleep apnea treatment. The product portfolio includes pediatric PAP masks for non-invasive ventilation, SmartMonitor infant apnea monitoring systems, NeoPAP products for neonatal respiratory therapy, and Synergy Cloud—a cloud-based platform for tracking and managing patient respiratory data. The company's mission centers on improving patient outcomes by providing healthcare organizations with real-time access to patient data, enabling better clinical decision-making, and facilitating earlier discharge of premature infants to home care settings.

ClariMed, Inc. is a global regulatory and human factors consulting firm headquartered in Chadds Ford, Pennsylvania, with offices across North America and Europe. Founded in 2022, the company specializes in user-centered design, human factors engineering, and quality management solutions for medical devices, combination products, and in-vitro diagnostics. ClariMed provides comprehensive end-to-end services including user needs assessments, contextual inquiries, human factors validation testing, regulatory compliance support, Quality Management System (QMS) implementation, UI/UX design, cybersecurity solutions, and strategic advisory services. The firm's multidisciplinary team brings expertise in human factors, industrial design, biomedical engineering, psychology, and quality engineering. ClariMed is ISO 13485:2016 certified and offers flexible engagement models—project-based consulting, embedded resources, retainer, and end-to-end support—to help MedTech and pharmaceutical companies accelerate time to market while ensuring safety, efficacy, and user satisfaction.